Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for MIA Syndrome in Peritoneal Dialysis Patients
NCT00390247Phase 4Withdrawn
- Sponsor
- The Chinese University of Hong Kong
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of thalidomide in Malnutrition-inflammation complex syndrome (MICS), sponsored by The Chinese University of Hong Kong. Planned start Jan 2007; status: withdrawn.
02
Drugs
thalidomide
03
Conditions
Malnutrition-inflammation complex syndrome (MICS)
Beyond the preview
Go deeper on NCT00390247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390247.